Bioscience News and Upcoming Events
News
Lonza's Rapid PyroCell® Monocyte Activation Test Systems Make Rabbit-Free Pyrogen Testing Faster, Easier, and More Efficient
Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine Human IL-6 Rapid ELISA Kit
Lonza Launches Nebula® Absorbance Reader for Streamlined Endotoxin and Pyrogen Testing
The new Lonza Nebula® Absorbance Reader provides QC labs with a fully optimized absorbance reader. It features high-performance optics and monochromator-based wavelength selection to ensure precise and accurate measurements of endotoxin levels, and reduces the risk of false positives or negatives.
Lonza Launches TheraPRO® CHO Media System to Improve Productivity and Quality in Therapeutic Protein Manufacture
Lonza just launched a new GS-CHO cell culture media system to optimize production of therapeutic monoclonal antibodies and recombinant proteins: The TheraPRO® CHO Media System.
Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium to Accelerate Cell Therapy Development
Lonza launches the TheraPEAK® T-VIVO® Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing.
New Lonza Webinar – "Taking the Leap into an MES from a CEO’s Perspective"
In this free 45-minute webinar, gain exclusive insight into the lessons the CEO of Exela® Pharma Sciences learned while implementing a Manufacturing Execution System (MES), and the lasting impact it will have on the company.
Fraunhofer IZI Selects Lonza’s MODA-ES® Solution to Digitalize Manufacturing Operations
The Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer IZI) has chosen Lonza’s MODA-ES® Manufacturing Execution System (MES) to streamline its manufacturing operations.